TAK-701 - Galaxy Biotech
Development activities: Discontinued projects (Takeda) - Oct 31, 2012 - TAK-701 discontinued in Advanced malignancies; The decision to discontinue development was made because it no longer fits in the product development portofolio of Takeda. 
Discontinued Oncology
http://www.takeda.com/company/publications/pdf/index/pipeline_20121031_en.pdf
 
Oct 31, 2012
 
 
068da575-5810-43bf-91ee-c2a9433839fc.jpg